Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Stephen Tindal, Director Softgel Formulation at Catalent, talks with Pharm Tech about manufacturing issues with soft gels.

Softgel Formulation and Manufacturing podcast

Melanie Sena is community editor of Pharmaceutical Technology.

Kansas State University to build Bulk Solids Innovation Center in Salina, Kansas.

Kansas State University to Build Bulk Solids Innovation Center

Governor Jerry Brown cites physician notification requirements for dispensing biosimilars as premature in the absence of FDA specifications for interchangeability.

California Governor Jerry Brown Vetoes Biosimilar Bill

Scientific Digital Imaging's Synbiosis Division introduces SynStats statistical analysis software.

New SynStats Software for Antibiotic and Vaccine Developers

HERMES PHARMA has pioneered user-friendly dosage forms. Our effervescent and chewable tablets, lozenges, orally disintegrating granules and instant drinks are convenient to use, easy to swallow and taste good.

User-friendly Solid Oral Dosage Forms

Aesica expands aseptic capabilities at its Nottingham, UK site with the acquisition of new pre-filled syringes manufacturing equipment.

Aesica Extends Aseptic Facilities to Include Pre-filled Syringes

Pfenex modifies its contract with US government for Anthrax vaccine.

Pfenex, US Government Extends Anthrax Vaccine Pact

3M Drug Delivery will manufacture transdermal patch for ProStrakan.

3M Drug Delivery to Manufacture Transdermal Patch in Europe

Advanced Biosciences Laboratories will support the development and production of a novel Shigella vaccine candidate for PATH.

Advanced Biosciences Laboratories, PATH Partner in Vaccine Production

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.